| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 133.41B | 129.54B | 126.72B | 121.34B | 101.27B | 97.73B |
| Gross Profit | 32.14B | 30.70B | 27.81B | 26.86B | 24.65B | 22.19B |
| EBITDA | 15.56B | 14.32B | 12.72B | 14.30B | 10.98B | 11.54B |
| Net Income | 10.36B | 9.55B | 8.50B | 6.09B | 6.84B | 7.44B |
Balance Sheet | ||||||
| Total Assets | 81.68B | 83.33B | 77.37B | 66.30B | 62.64B | 55.52B |
| Cash, Cash Equivalents and Short-Term Investments | 13.65B | 18.77B | 22.03B | 8.73B | 13.41B | 19.11B |
| Total Debt | 26.50B | 26.50B | 26.50B | 18.50B | 18.50B | 19.25B |
| Total Liabilities | 35.29B | 37.61B | 37.02B | 30.54B | 29.89B | 27.28B |
| Stockholders Equity | 46.39B | 45.72B | 40.34B | 35.77B | 32.75B | 28.24B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.05B | 9.43B | -1.54B | -2.50B | 14.71B |
| Operating Cash Flow | 0.00 | 1.16B | 9.50B | -1.47B | -2.49B | 14.72B |
| Investing Cash Flow | 0.00 | -152.00M | -192.00M | -85.00M | -20.00M | -21.00M |
| Financing Cash Flow | 0.00 | -4.27B | 3.99B | -3.13B | -3.19B | -4.73B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥57.85B | 9.84 | ― | 0.45% | 15.55% | 124.87% | |
75 Outperform | ¥240.32B | 17.83 | 23.24% | 2.13% | 12.05% | 25.60% | |
74 Outperform | ¥170.35B | 12.34 | ― | 2.33% | 4.90% | 11.86% | |
73 Outperform | ¥130.36B | 20.19 | 15.81% | 2.93% | 53.39% | 67.02% | |
62 Neutral | ¥72.47B | 8.53 | ― | 2.89% | 33.75% | -0.68% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
58 Neutral | ¥207.14B | 9.79 | 20.50% | 1.49% | 2.44% | -71.52% |